Transgenic mice overexpressing the neurotrophic factor S-100β show neuronal cytoskeletal and behavioral signs of altered aging processes: Implications for Alzheimer's disease and Down's syndrome

Brain Research

Volumn 776, Issue 1-2, 1997, Pages 51-60

  Whitaker Azmitia, Patricia M ^a   Wingate, Michael ^a   Borella, Alice ^a   Gerlai, Robert ^b   Roder, John ^b   Azmitia, Efrain C ^c  

^a STONY BROOK UNIVERSITY   (United States)

^b MOUNT SINAI HOSPITAL   (Canada)

^c NEW YORK UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Dendrite; Down's syndrome; Hippocampus; MAP 2; Neurofibrillary tangle; Neuronal cytoskeleton; S 100

Indexed keywords

MICROTUBULE ASSOCIATED PROTEIN 2; NEUROTROPHIC FACTOR; PROTEIN S 100;

AGING; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DOWN SYNDROME; GROWTH REGULATION; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS REGULATION; TRANSGENIC MOUSE;

AGING; ALZHEIMER DISEASE; ANIMALS; BEHAVIOR, ANIMAL; CALCIUM-BINDING PROTEINS; CYTOSKELETON; DENDRITES; DOWN SYNDROME; EXONS; GENE EXPRESSION REGULATION; HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, TRANSGENIC; MICROTUBULE-ASSOCIATED PROTEINS; NERVE GROWTH FACTORS; NEUROFIBRILLARY TANGLES; NEURONS; S100 PROTEINS; TRANSCRIPTION, GENETIC;

EID: 0031446195     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)01002-0     Document Type: Article

References (33)

1. Allore R., O'Hanlon D., Price R., Neilson K., Willard H.F., Cox D.R., Marks A., Dunn R.J. Gene encoding the beta subunit of S-100 protein is on chromosome 21: implications for Down's syndrome. Science. 239:1988;1311-1313.
2. Arendt T., Hanisch F., Holzer M., Bruckner M.K. In vivo phosphorylation in the rat basal nucleus induces PHF-like and APP immunoreactivity. Neuroreport. 5:1994;1397-1400.
3. Azmitia E.C., Dolan K., Whitaker-Azmitia P.M. S-100β but not NGF, EGF, insulin or calmodulin functions as a CNS serotonergic growth factor. Brain Res. 516:1990;354-360.
4. 1a agonist and dexamethasone reversal of PCA-induced loss of MAP-2 and synaptophysin immunoreactivity in adult rat brain. Brain Res. 677:1995;181-185.
5. Benowitz L.I., Routtenberg A. A membrane phosphoprotein associated with neural development, axon regeneration, phospholipid metabolism and synaptic plasticity. Trends Neurosci. 10:1987;527-529.
6. Caceres A., Busciglio J., Ferreira A., Steward O. An immunocytochemical and biochemical study of the microtubule associate protein MAP-2 during post-lesion dendritic re-modeling in the central nervous system of adult rats. Mol. Brain Res. 3:1988;233-238.
7. Chamak B., Fellous A., Glowinski J., Prochiantz A. MAP-2 expression and neuritic outgrowth and branching are co-regulated through region-specific neuro-astroglial interactions. J. Neurosci. 7:1987;3163-3171.
8. Diez-Guerra F.J., Avila J. An increase in phosphorylation of microtubule-associated protein 2 accompanies dendrite extension during the differentiation of cultured hippocampal neurons. Eur. J. Biochem. 227:1995;68-77.
9. Friend W.C., Clapoff S., Landry C., Becker L.E., O'Hanlon D., Allore R.J., Brown I.R., Marks A., Roder J., Dunn R.J. Cell-specific expression of high levels of human S-100β in transgenic mouse brain is dependent on gen dosage. J. Neurosci. 12:1992;4337-4346.
10. Gerlai R., Wojtowicz J.M., Marks A., Roder J. Overexpression of a calcium binding protein, S-100β in astrocytes impairs synaptic plasticity and spatial learning in transgenic mice. Learn. Memory. 2:1995;26-31.
11. Goodison K.L., Parahd I.M., White C.L., Sima A.A., Clark A.W. Neuronal and glial gene expression in neocortex of Down's syndrome and Alzheimer's disease. J. Neuropath. Exp. Neurol. 52:1993;192-196.
12. Griffin W.S.T., Stanley E.C., Ling C, White J., MacLeod V., Perrot L.J., White C.L., Araoz C. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. USA. 86:1989;7611-7619.
13. Hesketh J., Baudier J. Evidence that S100 proteins regulate microtubule assembly and stability in rat brain extracts. Int. J. Biochem. 18:1986;691-695.
14. Kato K., Suzuki F., Kurobe N., Okajima K., Ogasawara N., Nagaya M., Yamanaka S. Enhancement of S-100 beta protein in blood of patients with Down's syndrome. J. Mol. Neurosci. 2:1990;109-114.
15. Kato K., Asano T., Inagaki T., Yamamoto T., Sato T. Aging of nervous system and S-100 proteins. Jpn. J. Geriat. 27:1990;287-292.
16. Kligman D., Marshak D. Purification and characterization of a neurite extension factor from bovine brain. Proc. Natl. Acad. Sci. USA. 82:1985;7136-7139.
17. Kosik K.S. Tau protein and neurodegeneration. Mol. Neurobiol. 4:1992;171-179.
18. Kosik K.S., Finch E.A. MAP-2 and tau separate into axonal and dendritic domains after the elaboration of morphologically distinct neurites: an immunocytochemical study of cultured rat cerebrum. J. Neurosci. 7:1987;3142-3153.
19. Kosik K.S., Duffy L.K., Dowling M.M., Abraham C., McCluskey A., Selkoe D.J. Microtubule-associated protein-2: monoclonal antibodies demonstrate the selective incorporation of certain epitopes into Alzheimer neurofibrillary tangles. Proc. Natl. Acad. Sci. USA. 81:1984;7941-7945.
20. Lewis D., Teyler T.J. Anti-S-100 serum blocks long-term potentiation in the hippocampal slice. Brain Res. 383:1986;159-166.
21. Lui J.P., Lauder J.M. S-100β and insulin-like growth-II differentially regulate growth of developing serotonin and dopamine neurons in vitro. J. Neurosci. Res. 33:1992;248-256.
22. Mito T., Becker L.E. Developmental changes of S-100 protein and glial fibrillary acidic protein in the brain in Down Syndrome. Exp. Neurol. 120:1993;170-176.
23. Muller C.M., Akhavan A.C., Bette M. Possible role of S-100 in glial-neuronal signaling involved in activity-dependent plasticity in the developing mammalian cortex. J. Chem. Neuroanat. 6:1993;215-227.
24. Papandrikoulou A., Doll T., Tucker R.P., Garner C.C., Matus A. Embryonic MAP-2 lacks the cross-linking sidearm sequences and dendritic targeting signal of adult MAP-2. Nature. 340:1989;650-654.
25. Riol H., Gaudreauly G., Cloutier J., Murthy M. Overexpression of the S-100β gene in Down's syndrome. A study in lymphocytes. Soc. Neurosci. Abstr. 20:1994;1646.
26. Sheng J.G., Mrak R.E., Griffin W.S. S-100β protein expression in Alzheimer disease: potential role in pathogenesis of neuritic plaques. J. Neurosci. Res. 39:1994;398-404.
27. Sheu F.S., Azmitia E.C., Marshak D.R., Parker P.J., Routtenberg A. Glial-derived S-100β protein selectively inhibits recombinant beta protein kinase c (PKC) phosphorylation of neuron-specific F1/GAP43. Mol. Brain Res. 21:1994;62-68.
28. Sinet P.M., Theophile D., Rahmani Z., Chettouh Z., Blouin J.L., Prieur M., Noel B., Delabar J.M. Mapping of the Down syndrome phenotype on chromosome 21 at the molecular level. Biomed. Pharmacol. 48:1994;247-256.
29. Singh V.K. Studies of neuroimmune markers in Alzheimer's disease. Mol. Neurobiol. 9:1994;73-81.
30. Takashima S., Iida K., Mito T., Arima M. Dendritic and histochemical development and aging in patients with Down's syndrome. J. Intell. Disability Res. 38:1994;265-273.
31. Tucker R.P. The roles of microtubule-associated proteins in brain morphogenesis: a review. Brain Res. Rev. 15:1990;101-120.
32. Whitaker-Azmitia P.M., Azmitia E. Stimulation of astroglial serotonin receptors produces media which regulates development of serotonergic neurons. Brain Res. 497:1989;80-86.
33. Whitaker-Azmitia P.M., Murphy R., Azmitia E.C. S-100 protein is released from astroglial cells by stimulation of 5-HT1a receptors and regulates development of serotonin neurons. Brain Res. 528:1990;155-159.